Further immune response evaluations in the S. sonnei 53G refinement study revealed that baseline S. sonnei anti-LPS serum IgA titers were heterogeneous across study groups and subjects with higher serum IgA titers were less likely to develop shigellosis. The gene discussed is CD79A; the disease is shigellosis.